In its third exit from an Indian portfolio company within a month, Asia focused hedge fund Steadview Capital has sold more stake in a publicly listed active pharmaceutical ingredients (API) maker. Steadview Capital Mauritius Ltd has pared nearly half of its stake in Hyderabad-based bulk drugs maker Neuland Laboratories Ltd to ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.